Company description
The outbreak of a new coronavirus (SARS-CoV-2) is driving China’s urgent public health actions, as well as an international concern. Infection prevention and control through diagnostic testing and quarantine has become critical. Creative Biolabs offers an in vitro diagnostic (IVD) reagent development platform for improved detection and control of SARS-CoV-2.
